Is the Pro-Life Movement on a Collision Course with the Coronavirus?
"Weighing ethical concerns about the use of fetal-derived tissue to develop medicines against the public health risk of refusing vaccines." - The Dispatch
"Weighing ethical concerns about the use of fetal-derived tissue to develop medicines against the public health risk of refusing vaccines." - The Dispatch
"This is an ethical dilemma that pro-life Christians have wrestled through long before the coronavirus. Given the role of old fetal cell lines in more than half a century of vaccine development—including options for a COVID-19 vaccine—many have been able to reconcile the use of fetal tissue from decades-old abortions while opposing the use of fetal tissue from new abortions for further testing." - CToday
"While the administration’s June decision ended NIH’s internal human fetal tissue experiments and the UCSF contract it funded, it did not halt another 200 projects outside of NIH using human fetal tissue that received a combined $115 million in taxpayer funds from NIH in 2018." - Washington Post
"...pro-life leaders welcomed the Trump administration's newly announced decision to halt internal research by a federal entity using tissue from electively aborted babies." - BPNews
"The NIH has not funded any fetal tissue trials in over a decade, but approximately $100 million of taxpayer money currently goes toward basic science experiments using aborted fetal tissue. That money would be vastly better spent on ethical research with considerably better chances of success" - W. Examiner